Up Close and Exciting: The NMDA Glutamate Receptor
X-ray crystallography reveals secrets of the glutamate receptor.
282 RESULTS
Sort By:
X-ray crystallography reveals secrets of the glutamate receptor.
While mice sleep, neurons sprout synapses to solidify fresh skills, according to a new study. The brain also keeps amyloid-β levels low while we snooze.
An amplification-based test picks up minute amounts of prion protein in the blood of asymptomatic carriers, but researchers wonder whether regulators will want to screen the population.
Death receptor role in Alzheimer's disease looks less likely than was originally thought following a high-profile paper in 2009.
Leaders protest recent decision to deny Medicare beneficiaries coverage of amyloid scans.
The proportion of seniors with dementia in England appears to be on the decline, new research suggests.
Researchers at AAIC 2013 report that an individual’s subjective sense of worsening memory could be an important predictor of cognitive impairment and dementia.
Update on compounds in Phase 2 and 3 trials from the Alzheimer's Association International Conference
Speakers at Alzheimer’s conference reviewed planned Phase 1 and prevention trials and preclinical studies.
Hunting for rare mutations that cause dementia, researchers have spotted, but not yet snagged, some tantalizing candidates.
A parkinsonism-associated ubiquitin ligase interacts with parkin to promote mitophagy.
Rare variants of AD share some common areas of brain atrophy, but are also unique by way of degeneration in specific functional networks that correspond with clinical symptoms.
Brain connections weaken years before cognition in sporadic and familial Alzheimer’s.
Preliminary data from Parkinson’s Progression Markers Initiative suggests that cerebrospinal fluid biomarkers distinguish the most rapidly progressing form of Parkinson’s.
Before cognition falters, Alzheimer’s disease wreaks havoc on synapses, the brain’s subcellular communication hubs.